Next Article in Journal
A Comprehensive Survey of Immune Cytolytic Activity-Associated Gene Co-Expression Networks across 17 Tumor and Normal Tissue Types
Previous Article in Journal
Peroxiredoxin II Regulates Cancer Stem Cells and Stemness-Associated Properties of Cancers
Previous Article in Special Issue
RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
Review

Targeting Raf Kinase Inhibitory Protein Regulation and Function

1
Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA
2
Committee on Cancer Biology, University of Chicago, Chicago, IL 60637, USA
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(9), 306; https://doi.org/10.3390/cancers10090306
Received: 18 July 2018 / Revised: 24 August 2018 / Accepted: 30 August 2018 / Published: 4 September 2018
(This article belongs to the Special Issue Targeting Raf Kinase Inhibitor Protein (RKIP) in Cancer)
Raf Kinase Inhibitory Protein (RKIP) is a highly conserved kinase inhibitor that functions as a metastasis suppressor in a variety of cancers. Since RKIP can reprogram tumor cells to a non-metastatic state by rewiring kinase networks, elucidating the mechanism by which RKIP acts not only reveals molecular mechanisms that regulate metastasis, but also represents an opportunity to target these signaling networks therapeutically. Although RKIP is often lost during metastatic progression, the mechanism by which this occurs in tumor cells is complex and not well understood. In this review, we summarize our current understanding of RKIP regulation in tumors and consider experimental and computational strategies for recovering or mimicking its function by targeting mediators of metastasis. View Full-Text
Keywords: RKIP; metastasis; suppressor; kinase; therapy; signaling RKIP; metastasis; suppressor; kinase; therapy; signaling
Show Figures

Figure 1

MDPI and ACS Style

Yesilkanal, A.E.; Rosner, M.R. Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers 2018, 10, 306. https://doi.org/10.3390/cancers10090306

AMA Style

Yesilkanal AE, Rosner MR. Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers. 2018; 10(9):306. https://doi.org/10.3390/cancers10090306

Chicago/Turabian Style

Yesilkanal, Ali E., and Marsha R. Rosner. 2018. "Targeting Raf Kinase Inhibitory Protein Regulation and Function" Cancers 10, no. 9: 306. https://doi.org/10.3390/cancers10090306

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop